Ulrike Glaenzel

495 citations
10 papers · 334 · h-index 8

Impact in

  • Genetics top 10%
    • Hemoglobinopathies and Related Disorders
  • Pharmacology top 10%
    • Pharmacogenetics and Drug Metabolism

Papers in

  • Oncology 4
    • Colorectal Cancer Treatments and Studies 2
  • Molecular Biology 3
    • PI3K/AKT/mTOR signaling in cancer 2
    • Histone Deacetylase Inhibitors Research 1
    • Sphingolipid Metabolism and Signaling 1
Co-authors
Felix Waldmeier (4 shared papers)Katharine Hazell (2 shared papers)Yi Jin (5 shared papers)Peter End (2 shared papers)John B. Porter (1 shared paper)Romain Séchaud (1 shared paper)Gerard Bruin (1 shared paper)Steve Warrington (1 shared paper)
Journals
Drug Metabolism and Disposition (7 papers)Pharmacology Research & Perspectives (1 paper)Cancer Chemotherapy and Pharmacology (1 paper)European Journal of Pharmaceutical Sciences (1 paper)
Partner nations
SwitzerlandUnited StatesIndia

In The Last Decade

Ulrike Glaenzel

10 papers receiving 321 citations

Peers

Ulrike Glaenzel
Comparison fields: 5 of 70
  • Genetics 81
  • Pharmacology 53
  • Hematology 58
  • Endocrinology, Diabetes and Metabolism 70
  • Pharmaceutical Science 19
Replace Naoaki Murao with:
Naoaki Murao Japan
Joe Murphy United States
Yvonne Pak United States
Upendra Marathi United States
Yan Xia China
Yasuhiro Sato Japan
Ellen A. Cannady United States
Koen G. A. M. Hussaarts Netherlands
H. Narjes Germany
Britta Landin Sweden
Ulrike Glaenzel relative to Naoaki Murao Japan Naoaki Murao's profile →
Citations per field
00.5×1.5×1.9×
Naoaki Murao · 1×
Citations per year

Countries citing papers authored by Ulrike Glaenzel

Since Specialization
Citations

This map shows the geographic impact of Ulrike Glaenzel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrike Glaenzel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrike Glaenzel more than expected).

Fields of papers citing papers by Ulrike Glaenzel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrike Glaenzel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrike Glaenzel. The network helps show where Ulrike Glaenzel may publish in the future.

Co-authors

The 25 scholars most cited alongside Ulrike Glaenzel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ulrike Glaenzel Line = papers co-authored together Ulrike Glaenzel links everyone, so they are left out of the graph.

All Works

10 of 10 papers shown
#Work
1
Absorption, Distribution, Metabolism, and Elimination of the Direct Renin Inhibitor Aliskiren in Healthy Volunteers
Drug Metabolism and Disposition ·Felix Waldmeier, Ulrike Glaenzel, B. Wirz, Lukas Oberer, Dietmar G. Schmid, Michael Seiberling, Jessica Valencia, Gilles‐Jacques Rivière, Peter End, Sujata Vaidyanathan
2007104
2
Pharmacokinetics, Metabolism, and Disposition of Deferasirox in β-Thalassemic Patients with Transfusion-Dependent Iron Overload Who Are at Pharmacokinetic Steady State
Drug Metabolism and Disposition ·Felix Waldmeier, Gerard Bruin, Ulrike Glaenzel, Katharine Hazell, Romain Séchaud, Steve Warrington, John B. Porter
201076
3
Metabolism and Disposition of Siponimod, a Novel Selective S1P1/S1P5 Agonist, in Healthy Volunteers and In Vitro Identification of Human Cytochrome P450 Enzymes Involved in Its Oxidative Metabolism
Drug Metabolism and Disposition ·Ulrike Glaenzel, Yi Jin, Robert Nufer, Wenkui Li, Kirsten Schroer, Sylvie Adam-Stitah, Sjoerd P. van Marle, Eric Legangneux, Hubert Borell, Alexander D. James, Axel Meißner, Gian Camenisch, Anne Gardin
201841
4
Absorption, Distribution, Metabolism, and Excretion of Capmatinib (INC280) in Healthy Male Volunteers and In Vitro Aldehyde Oxidase Phenotyping of the Major Metabolite
Drug Metabolism and Disposition ·Ulrike Glaenzel, Yi Jin, Regine Hansen, Kirsten Schroer, Gholamreza Rahmanzadeh, Ulrike Pfaar, Jan Jaap van Lier, Hubert Borell, Axel Meißner, Gian Camenisch, Sylvia Zhao
202031
5
Absorption, distribution, metabolism, and excretion of [14C]BYL719 (alpelisib) in healthy male volunteers
Cancer Chemotherapy and Pharmacology ·Alexander D. James, Lars Blumenstein, Ulrike Glaenzel, Yi Jin, Arnold Demailly, Annamária Jakab, Regine Hansen, Katharine Hazell, Anuradha Mehta, Lucia Trandafir, Piet Swart
201530
6
An integrated assessment of the ADME properties of the CDK4/6 Inhibitor ribociclib utilizing preclinical in vitro, in vivo, and human ADME data
Pharmacology Research & Perspectives ·Alexander D. James, Hilmar Schiller, Cyrille Marvalin, Yi Jin, Hubert Borell, Ad F. Roffel, Ulrike Glaenzel, Yan Ji, Gian Camenisch
202018
7
Absorption, Distribution, Metabolism, and Excretion of the Oral Prostaglandin D2 Receptor 2 Antagonist Fevipiprant (QAW039) in Healthy Volunteers and In Vitro
Drug Metabolism and Disposition ·David Pearson, H. Weiss, Yi Jin, Jan Jaap van Lier, Veit J. Erpenbeck, Ulrike Glaenzel, Peter End, Ralph Woessner, Fabian Eggimann, Gian Camenisch
201716
8
PIMECROLIMUS: ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION IN HEALTHY VOLUNTEERS AFTER A SINGLE ORAL DOSE AND SUPPLEMENTARY INVESTIGATIONS IN VITRO
Drug Metabolism and Disposition ·Markus Zollinger, Felix Waldmeier, Stefan Hartmann, Gerhard Zenke, Alfred Zimmerlin, Ulrike Glaenzel, J P Baldeck, Alain Schweitzer, Stephane Berthier, Thomas Moenius, Maximilian A. Grassberger
200611
9
Metabolism and disposition of the oral absorption enhancer 14C-radiolabeled 8-(N-2-hydroxy-5-chlorobenzoyl)-amino-caprylic acid (5-CNAC) in healthy postmenopausal women and supplementary investigations in vitro
European Journal of Pharmaceutical Sciences ·Hans-Peter Gschwind, Ulrike Glaenzel, Felix Waldmeier, B. Wirz, Helene D. Sabia, Franck Picard, H. Weiss, Leslie Choi, Pieter Swart, Ajithkumar Vasudevan, M. Azria
20125
10
Absorption, Distribution, Metabolism, and Excretion of Icenticaftor (QBW251) in Healthy Male Volunteers at Steady State and In Vitro Phenotyping of Major Metabolites
Drug Metabolism and Disposition ·Ulrike Glaenzel, Felix Huth, Fabian Eggimann, Melissa Hackling, Luc Alexis Leuthold, Axel Meißner, Lidiya Bebrevska
20242

About Ulrike Glaenzel

Ulrike Glaenzel is a scholar working on Oncology, Molecular Biology, Pharmacology, Pulmonary and Respiratory Medicine and Pharmacology, having authored 10 papers that have together received 334 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Inflammatory mediators and NSAID effects (2 papers), Pharmacological Effects and Toxicity Studies (1 paper), Freezing and Crystallization Processes (1 paper), Hemoglobinopathies and Related Disorders (1 paper), Histone Deacetylase Inhibitors Research (1 paper) and Sphingolipid Metabolism and Signaling (1 paper). The work is most often cited by research in Genetics (81 citations), Pharmacology (53 citations), Hematology (58 citations), Endocrinology, Diabetes and Metabolism (70 citations) and Pharmaceutical Science (19 citations). Ulrike Glaenzel has collaborated with scholars based in Switzerland, United States and India. Frequent co-authors include Felix Waldmeier, Katharine Hazell, Yi Jin, Peter End, John B. Porter, Romain Séchaud, Gerard Bruin, Steve Warrington, B. Wirz and Jessica Valencia. Their work appears in journals such as Drug Metabolism and Disposition, Pharmacology Research & Perspectives, Cancer Chemotherapy and Pharmacology and European Journal of Pharmaceutical Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Naoaki MuraoBreakdown of academic impact, for papers by Joe MurphyBreakdown of academic impact, for papers by Yvonne PakBreakdown of academic impact, for papers by Upendra MarathiBreakdown of academic impact, for papers by Yan XiaBreakdown of academic impact, for papers by Yasuhiro SatoBreakdown of academic impact, for papers by Ellen A. CannadyBreakdown of academic impact, for papers by Koen G. A. M. HussaartsBreakdown of academic impact, for papers by H. NarjesBreakdown of academic impact, for papers by Britta Landin